🎉 M&A multiples are live!
Check it out!

Youcare Pharmaceutical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Youcare Pharmaceutical and similar public comparables like Pharming, Galapagos, and Benevolent AI.

Youcare Pharmaceutical Overview

About Youcare Pharmaceutical

Youcare Pharmaceutical Group Co Ltd is a pharmaceutical group enterprise integrating new drug research and development, drug production, circulation and sales.


Founded

2001

HQ

China
Employees

n/a

Website

youcareyk.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$893M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Youcare Pharmaceutical Financials

Youcare Pharmaceutical has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Youcare Pharmaceutical achieved revenue of $521M and an EBITDA of $52.7M.

Youcare Pharmaceutical expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Youcare Pharmaceutical valuation multiples based on analyst estimates

Youcare Pharmaceutical P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $578M $521M XXX XXX XXX
Gross Profit $405M $362M XXX XXX XXX
Gross Margin 70% 70% XXX XXX XXX
EBITDA $57.2M $52.7M XXX XXX XXX
EBITDA Margin 10% 10% XXX XXX XXX
Net Profit $46.2M $25.5M XXX XXX XXX
Net Margin 8% 5% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Youcare Pharmaceutical Stock Performance

As of April 15, 2025, Youcare Pharmaceutical's stock price is CNY 16 (or $2).

Youcare Pharmaceutical has current market cap of CNY 7.3B (or $1.0B), and EV of CNY 6.5B (or $893M).

See Youcare Pharmaceutical trading valuation data

Youcare Pharmaceutical Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$893M $1.0B XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Youcare Pharmaceutical Valuation Multiples

As of April 15, 2025, Youcare Pharmaceutical has market cap of $1.0B and EV of $893M.

Youcare Pharmaceutical's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Youcare Pharmaceutical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Youcare Pharmaceutical and 10K+ public comps

Youcare Pharmaceutical Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $893M XXX XXX XXX
EV/Revenue 1.7x XXX XXX XXX
EV/EBITDA 16.9x XXX XXX XXX
P/E 58.7x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 81.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Youcare Pharmaceutical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Youcare Pharmaceutical Valuation Multiples

Youcare Pharmaceutical's NTM/LTM revenue growth is n/a

Youcare Pharmaceutical's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, Youcare Pharmaceutical's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Youcare Pharmaceutical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Youcare Pharmaceutical and other 10K+ public comps

Youcare Pharmaceutical Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -10% XXX XXX XXX XXX
EBITDA Margin 10% XXX XXX XXX XXX
EBITDA Growth -8% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee n/a XXX XXX XXX XXX
S&M Expenses to Revenue 33% XXX XXX XXX XXX
G&A Expenses to Revenue 2% XXX XXX XXX XXX
R&D Expenses to Revenue 10% XXX XXX XXX XXX
Opex to Revenue 51% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Youcare Pharmaceutical Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics and Contract Research & Manufacturing comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Youcare Pharmaceutical M&A and Investment Activity

Youcare Pharmaceutical acquired  XXX companies to date.

Last acquisition by Youcare Pharmaceutical was  XXXXXXXX, XXXXX XXXXX XXXXXX . Youcare Pharmaceutical acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Youcare Pharmaceutical

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Youcare Pharmaceutical

When was Youcare Pharmaceutical founded? Youcare Pharmaceutical was founded in 2001.
Where is Youcare Pharmaceutical headquartered? Youcare Pharmaceutical is headquartered in China.
Is Youcare Pharmaceutical publicy listed? Yes, Youcare Pharmaceutical is a public company listed on SHG.
What is the stock symbol of Youcare Pharmaceutical? Youcare Pharmaceutical trades under 688658 ticker.
When did Youcare Pharmaceutical go public? Youcare Pharmaceutical went public in 2020.
Who are competitors of Youcare Pharmaceutical? Similar companies to Youcare Pharmaceutical include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Youcare Pharmaceutical? Youcare Pharmaceutical's current market cap is $1.0B
What is the current revenue growth of Youcare Pharmaceutical? Youcare Pharmaceutical revenue growth between 2023 and 2024 was -10%.
Is Youcare Pharmaceutical profitable? Yes, Youcare Pharmaceutical is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.